Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.

Scientific Reports
Sara RedaHeiko Rühl

Abstract

Functional tests for lupus anticoagulants (LA) as part of a thrombophilia workup are commonly performed in patients under anticoagulant therapy that may interfere with assay results. There is no consensus on how these tests should be assessed in patients on direct oral anticoagulants (DOACs). In this retrospective cohort study, we analysed data from patients with a history of thrombosis in whom dilute Russell viper venom time (dRVVT), LA-sensitive aPTT, and solid phase assays for antiphospholipid antibodies (aPL) were performed (n = 3,147, thereof 588 on rivaroxaban, 144 on apixaban, 1,179 on other anticoagulant drugs). The dRVVT ratio was correlated with rivaroxaban (r = 0.30, P < 10-4) but not with apixaban plasma levels. The LA-sensitive aPTT/aPTT ratio showed no correlation with DOAC levels. Correspondingly, the rate of patients with abnormal dRVVT test was significantly higher (P < 10-4) under rivaroxaban (88%) than in thrombosis patients without anticoagulant medication (6%), independent from their aPL plasma levels. No isolated positive results of functional LA testing in patients on anticoagulants could be confirmed in repeated testing after discontinuation of the medication (n = 40). These data indicate that rivaroxaba...Continue Reading

References

Oct 1, 1989·British Journal of Haematology·D A Triplett, J Brandt
May 24, 2003·The Hematology Journal : the Official Journal of the European Haematology Association·Monica Galli, Tiziano Barbui
Feb 5, 2005·Pathophysiology of Haemostasis and Thrombosis·Monica Galli
Sep 6, 2006·Thrombosis and Haemostasis·Amelia RuffattiVittorio Pengo
Jul 25, 2009·Journal of Thrombosis and Haemostasis : JTH·V PengoUNKNOWN Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the Interna
Nov 26, 2010·Thrombosis and Haemostasis·Eileen MerrimanHuyen Tran
Jun 15, 2011·Journal of Thrombosis and Haemostasis : JTH·G M A van OsPh G de Groot
Feb 9, 2012·British Journal of Haematology·David KeelingUNKNOWN British Committee for Standards in Haematology
Feb 7, 2014·Seminars in Thrombosis and Hemostasis·Gary W Moore
Jun 27, 2014·Journal of Thrombosis and Haemostasis : JTH·A HillarpT L Lindahl
Apr 9, 2015·Journal of Thrombosis and Haemostasis : JTH·D R J ArachchillageH Cohen
Apr 15, 2016·Thrombosis and Haemostasis·Franz RatzingerPeter Quehenberger
Jun 24, 2017·Thrombosis and Haemostasis·Aleksandra AntovicJovan Antovic
Aug 9, 2017·Blood Reviews·Shruti Chaturvedi, Keith R McCrae
Sep 21, 2017·The New England Journal of Medicine·Jean M Connors
Dec 2, 2017·Journal of Thrombosis and Haemostasis : JTH·J DouxfilsF Mullier
Oct 4, 2018·Scandinavian Journal of Clinical and Laboratory Investigation·Andreas HillarpTomas L Lindahl
Jun 30, 2019·TH Open : Companion Journal to Thrombosis and Haemostasis·Paul Y KimJeffrey I Weitz

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
blood draw
ELISA

Software Mentioned

XLSTAT

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.